SanBio's Stem Cell Research Shows Promise for Neurological Disorder Treatments

TipRanksJan 7 01:55 ET

SanBio to Acquire and Cancel 8,300 Share Acquisition Rights

MT NewswiresDec 17, 2024 06:54 ET

Jefferies Adjusts SanBio's Price Target to 280 Yen From 270 Yen, Keeps at Underperform

MT NewswiresDec 17, 2024 04:26 ET · Ratings

SanBio 9-Mos Loss Y2.15B Vs Loss Y1.88B

Dow JonesDec 16, 2024 01:30 ET

SanBio Completes Second Production Run of Stem Cell Therapy Akuugo

MT NewswiresDec 8, 2024 18:18 ET

SanBio Faces Minor Delay in AKUUGO Production

TipRanksNov 15, 2024 01:53 ET